These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34568129)

  • 41. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
    Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
    Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The clinical and immunological characteristics of COVID-19 patients with delayed SARS-CoV-2 virus clearance.
    Wang J; Li D; Tang B; Sun X; Shi W; Li H; Zhang Z; Wu Y; Zhang Y; Qiao Q
    Immun Inflamm Dis; 2023 Sep; 11(9):e999. PubMed ID: 37773701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dynamic Differences of Immunological Parameters Between Severe and Non-severe COVID-19 Patients.
    Li Q; Xu W; Li W; Huang C; Fei L; Xie X; Chen L
    Discov Med; 2021; 31(163):79-87. PubMed ID: 34965375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients.
    Gozzi-Silva SC; Oliveira LM; Alberca RW; Pereira NZ; Yoshikawa FS; Pietrobon AJ; Yendo TM; de Souza Andrade MM; Ramos YAL; Brito CA; Oliveira EA; Beserra DR; Orfali RL; Aoki V; Duarte AJDS; Sato MN
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of hematological parameters alterations in different waves of COVID-19 pandemic: A cross-sectional study.
    Charostad J; Rezaei Zadeh Rukerd M; Shahrokhi A; Aghda FA; Ghelmani Y; Pourzand P; Pourshaikhali S; Dabiri S; Dehghani A; Astani A; Nakhaie M; Kakavand E
    PLoS One; 2023; 18(8):e0290242. PubMed ID: 37624800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
    Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of Hematological Parameters Between Survivors and Non-Survivors COVID-19 Patients in Saudi Arabia.
    Binsaleh NK; Eltayeb R; Sherwani S; Almishaal AA; Hindi EA; Qanash H; Bazaid AS; Alharbi AO; Bazaid MB; Altamimi SA
    Int J Gen Med; 2023; 16():3955-3962. PubMed ID: 37670931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.
    Du H; Dong X; Zhang JJ; Cao YY; Akdis M; Huang PQ; Chen HW; Li Y; Liu GH; Akdis CA; Lu XX; Gao YD
    Allergy; 2021 Feb; 76(2):510-532. PubMed ID: 32524611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis.
    Khalid A; Ali Jaffar M; Khan T; Abbas Lail R; Ali S; Aktas G; Waris A; Javaid A; Ijaz N; Muhammad N
    Hematology; 2021 Dec; 26(1):529-542. PubMed ID: 34334100
    [No Abstract]   [Full Text] [Related]  

  • 51. Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.
    Sciacchitano S; De Vitis C; D'Ascanio M; Giovagnoli S; De Dominicis C; Laghi A; Anibaldi P; Petrucca A; Salerno G; Santino I; Amodeo R; Simmaco M; Napoli C; Tafuri A; Di Napoli A; Sacconi A; Salvati V; Ciliberto G; Fanciulli M; Piaggio G; de Latouliere L; Ricci A; Mancini R
    J Transl Med; 2021 Apr; 19(1):139. PubMed ID: 33794925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
    Xu B; Fan CY; Wang AL; Zou YL; Yu YH; He C; Xia WG; Zhang JX; Miao Q
    J Infect; 2020 Jul; 81(1):e51-e60. PubMed ID: 32315725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Restrictive type and infectious complications might predict nadir hematological values among individuals with anorexia nervosa during the refeeding period: a retrospective study.
    Funayama M; Koreki A; Mimura Y; Takata T; Ogino S; Kurose S; Shimizu Y; Kudo S
    J Eat Disord; 2022 May; 10(1):64. PubMed ID: 35513879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hematological findings and complications of COVID-19.
    Terpos E; Ntanasis-Stathopoulos I; Elalamy I; Kastritis E; Sergentanis TN; Politou M; Psaltopoulou T; Gerotziafas G; Dimopoulos MA
    Am J Hematol; 2020 Jul; 95(7):834-847. PubMed ID: 32282949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of HIV and malaria parasites co-infection on immune-hematological profiles among patients attending anti-retroviral treatment (ART) clinic in Infectious Disease Hospital Kano, Nigeria.
    Jegede FE; Oyeyi TI; Abdulrahman SA; Mbah HA; Badru T; Agbakwuru C; Adedokun O
    PLoS One; 2017; 12(3):e0174233. PubMed ID: 28346490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.
    Xiong L; Li Q; Cao X; Xiong H; Huang M; Yang F; Liu Q; Meng D; Zhou M; Wang G; Tong J; Chen T; Zhang Y; He X; Fan Y; Zhang Y; Tang L; Jin Y; Xia J; Hu Y
    BMC Med; 2021 Jul; 19(1):163. PubMed ID: 34256745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths.
    Xiong L; Zang X; Feng G; Zhao F; Wang S; Zeng W; Yu K; Zhai Y
    Aging (Albany NY); 2021 Mar; 13(5):6289-6297. PubMed ID: 33711813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?
    Tahir Huyut M; Huyut Z; İlkbahar F; Mertoğlu C
    Int Immunopharmacol; 2022 Apr; 105():108542. PubMed ID: 35063753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.